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Abstract
Development of new effective treatments for glaucomatous optic neuropathy is one of the most acute aspects of modern oph-
thalmology.
The aim of the work is to investigate the effectiveness of cell therapy with postnatal multipotent neural crest stem cells (NCSCs) 
using different cell delivery methods in a model of adrenaline-induced glaucoma.
Materials and methods. Glaucoma was induced in Wistar rats by intraperitoneal injections of 10 μg to 15 μg/100 g body weight 
of 0.18 % adrenaline hydrotartrate. NCSCs were delivered intravenously (5 million cells), retrobulbarly (0.5 million cells) or parabulbar-
ly (0.5 million cells). Histomorphometric analysis of the retina was performed on stained haematoxylin-eosin sections with a thickness 
of 5 μm one month after the delivery of NCSCs.
Results. NCSCs transplantation by all modes of delivery caused positive morphological changes to varying degrees. Intrave-
nous administration induced a decrease in edema in all retinal layers and a slight restoration of the cytoarchitectonics of the retinal 
layers. The parabulbar administration of NCSCs led to a decrease in edema and the restoration of the cytoarchitectonics of the layers, 
most pronouncedly the ganglion cell layer and the inner retinal layer. After the retrobulbar administration of NCSCs, the reduction in 
edema and restoration of the cytoarchitectonics of the layers were the most pronounced.
Conclusions. According to the results of the study, the positive effect of NCSCs transplantation in an experimental model of 
glaucoma was the most pronounced following the retrobulbar injection of cells. Further investigations of the mechanisms of the effect 
of transplanted NCSCs on retinal structure restoration are needed.
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1. Introduction
Glaucoma is one of the leading causes of blindness and disability worldwide [1, 2]. Accord-
ing to an epidemiological study, the number of people with glaucoma will increase by 74 % from 
2013 to 2040 [3].
Glaucoma is defined as progressive optic neuropathy characterized by the excitation of the 
optic disc and a corresponding decrease in retinal sensitivity [1, 4]. Glaucoma optic neuropathy 
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involves the progressive loss of retinal ganglion cells and their axons, the induction of which is 
influenced by both external and internal factors [5, 6].
Many experimental studies using modern science techniques have been carried out, and it 
has been shown that multipotent stem cells have a positive effect in ophthalmology [7]. Advances in 
regenerative medicine and cell therapy are based on the unique properties of stem cells, including 
their ability to self-renew and differentiate into specific cell types, and the prospects for clinical 
use are virtually limitless [8–10].
Given the steady increase in the morbidity of glaucoma and the associated progressive dete-
rioration and loss of visual function, which leads to disability and disability, glaucoma is a socially 
significant disease Thus, developing new effective treatments for glaucoma is one of the most press-
ing challenges in modern ophthalmology. A promising strategy for the treatment of glaucoma is cell 
therapy using stem cells, but an important consideration is determining the appropriate cell type.
In our study, we focused on multipotent neural crest stem cells (NCSCs). Several studies have 
shown that NCSCs are able to transdifferentiate into CNS cell types both in vitro and after in vivo 
transplantation [11–13]. In recent years, postnatal NCSCs has been identified in a number of tissues 
and organs of adult mammals, including humans. Thus, NCSCs demonstrate 2 basic properties of 
stem cells (SCs): the ability to self-renew and the potential for multilinear differentiation [14].
The goal of this work was to investigate the effectiveness of cell therapy with postnatal 
multipotent neural crest stem-derived stem cells using various delivery methods for the treatment 
of adrenaline-induced glaucoma.
2. Materials and methods
In experimental work, there were 50 Wistar rats (10–12 months, male). Laboratory ani-
mals were divided into 5 groups: intact animals group (n=10), glaucoma-modelling group without 
NCSCs (n=10), glaucoma-modelling group with intravenous injections of NCSCs (n=10), glauco-
ma-modelling group with parabulbar injection of NCSCs (n=10), glaucoma-modelling group with 
retrobulbar injection of NCSCs (n=10). 
Glaucoma was induced by intraperitoneal injections of 10 μg to 15 μg/100 g body weight of 
0.18 % adrenaline hydrotartrate. Twenty injections were administered over 6 weeks, with an aver-
age of 3 injections per week. After every 5 injections, the dose of injected adrenaline was increased 
[15]. Intraocular pressure (IOP) was measured with an applanation tonometer (Icare® TONOVET 
tonometer, Finland).
During the experiment, bioethical principles, legislation and biomedical research require-
ments, namely, the Declaration of Helsinki (1964–2013), the Constitution of Ukraine and the Civil 
Code of Ukraine (2006), the Basics of the Legislation of Ukraine on Health Care (1992), and the 
Guidelines of Clinical Research of the Ministry of Health of Ukraine No. 42-7.0: 2005 “Medicines. 
Good Clinical Practice” (2005), Model Regulations on Ethics Commissions for Clinical Trials (Or-
der of the Ministry of Health of Ukraine No. 690 of 23-9.2009), Law of Ukraine No. 3447-IV “On 
protection of animals from ill-treatment” (2006) were observed.
Rat NCSCs were obtained from hair follicles by vibration and cultured according to a 
previously described method [16]. Rat NCSCs were characterized by immunofluorescence anal-
ysis. NCSCs were transplanted intravenously (5 million cells in 0.5 ml of saline), retrobulbarly – 
(0.5 million cells in 0.05 ml of saline) or parabulbarly (0.5 million cells in 0.05 ml of saline). Histo-
morphometric analysis of the retina and optic nerve was performed on haematoxylin-eosin stained 
sections with a thickness of 5 μm.
3. Results
Rat NCSCs expressed markers characteristic of cells originating from the neural crest, 
namely, the transcription factor Sox10 and the intermediate filament protein Nestin (Fig. 1).
The IOP of rats prior to the start of glaucoma modelling was 7–8 mm Hg. Histological 
preparations of the retinas of intact rats are presented in Fig. 2. After glaucoma modelling, the 
IOP was 20–22 mm Hg. One month after glaucoma modelling, histological specimens exhibited 
glaucoma optic neuropathy, specifically swelling of all retinal layers; axonal degeneration in the 
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nerve fibre layer; partial detachment from the ganglion cell layer; apoptosis and cell necrosis in the 
ganglion cell layer; loosening and increased thickness of the inner mesh layer and the appearance 
of cell nuclei; thinning and breaking of the outer mesh layer and the appearance of cell nuclei; the 
disruption of cytoarchitectonics in the inner and outer nuclear layers; a reduction in the number 
of pycnotic nuclei in these layers; increased thickness of the photoreceptor layer; and stasis and 
haemorrhage in the choroid (Fig. 3).
a                                          b
c                                        d
Fig. 1. Immunofluorescence analysis of NCSCs in rats: a – detection of the transcription  
factor Sox10 (green); b – detection of the intermediate filament protein Nestin (red);  
c – hoechst 33342 staining of cell nuclei (blue); d – merged image. Scale bar=20 microns.
Fig. 2. Histological preparations of the retinas of intact rats. Haematoxylin-eosin staining













According to the results of the study, NCSCs transplantation by all modes of delivery 
caused positive morphological changes in the retina to varying degrees. Intravenous administra-
tion reduced the swelling of all retinal layers but did little to restore the cytoarchitectonics of the 
retinal layers (Fig. 4). Parabulbar administration of NCSCs led to a decrease in edema and the 
restoration of the cytoarchitectonics of the layers, most pronouncedly the ganglion cell layer and 
the inner retinal layer. Significant edema was maintained in the outer nuclear and photoreceptor 
layers (Fig. 5).
Fig. 4. Histological preparations of the retinas of glaucoma model rats injected intravenously with 
cells. Haematoxylin-eosin staining
Fig. 5. Histological preparations of the retinas of glaucoma model rats injected parabulbarly with 
cells. Haematoxylin-eosin staining
After the retrobulbar administration of NCSCs, the reduction in edema and the restoration 
of the cytoarchitectonics of the layers were the most pronounced (Fig. 6).
Fig. 6. Histological preparations of the rat retinas of glaucoma rats injected retrobulbarly with 
cells. Haematoxylin-eosin staining
4. Discussion
The number of glaucoma patients is increasing, and glaucoma is one of the most debilitating 










effective treatments for glaucoma is one of the pressing challenges of modern ophthalmology. A 
promising strategy is cell therapy using stem cells.
An important consideration of cell therapy is choosing the appropriate cell type. In our 
study, we focused on multipotent neural crest stem cells (NCSCs). This is because of the easy ac-
cessibility of these cells, the minimally invasive procedure required to obtain them, and their bio-
logical properties, namely, their potential for multilinear differentiation and their ability to produce 
a wide range of growth factors and cytokines with neurotrophic, neuroprotective, anti-angiogenic 
and apoptotic effects [17].
With respect to the biological properties of NCSCs, it should be noted that they have the 
potential to differentiate into major cell types, namely, nerve crest derivatives such as neurons 
and glia of the peripheral nervous system, melanocytes, stromal cells, corneal endothelial cells, 
and some types of endocrine cells [14]. Importantly, there is experimental evidence that NCSCs 
are capable of linear conversion into CNS neuronal stem cells [11]. In addition, NCSCs can 
transdifferentiate into CNS cell types, such as oligodendrocytes, after transplantation into a new 
microenvironment [13]. This provides a basis for studying the possible transdifferentiation of 
NCSCs into retinal ganglion cells and photoreceptor cells. In addition to potentially being able 
to directly integrate into damaged tissues, NCSCs can also realize their regenerative potential 
through paracrine action. Thus, they have been found to produce a wide range of neurotrophic 
factors (brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), 
neurotrophin 3, neurotrophin 4/5 and nerve growth factor (NGF)) and growth factors (the major 
fibroblast growth factor FG, vascular endothelial growth factor (VEGF), etc.), which determines 
their neuroprotective and regenerative potential. In summary, these properties make postnatal 
NCSCs promising cells for the development of new treatments for diseases of the cornea, retina, 
and optic nerve [18, 19].
To date, numerous studies have shown that the use of cell therapy for the treatment of 
experimental glaucoma has a positive effect, but the results are controversial and not consis-
tent [8, 9, 20].
NCSCs demonstrate 2 basic properties of SCs: the ability to self-renew and the potential 
for multilinear differentiation. A very promising source for the isolation and cultivation of NCSCs 
from animals and humans are hair follicles, and the procedure for obtaining a small skin biopsy 
specimen from a patient is minimally invasive [16].
Our study demonstrates that cell therapy with NCSCs through all delivery methods used has 
a positive effect on retinal structure. One month after the intravenous delivery of NCSCs, there was 
a significant decrease in edema and partial restoration of the structure of all layers of the retina, 
and after parabulbar administration, these positive changes were even more robust. However, the 
most pronounced positive changes involving the reduction in edema and the restoration of retinal 
structure were observed after the retrobulbar administration of NCSCs.
Study limitations. A limitation of our study is the study of the effect of cell therapy only on 
morphological changes in the structure of the retina.
Prospects for further research. Prospective directions of further research in our opinion is 
to study the effect of cell therapy in glaucoma on the structure of the optic nerve, to determine the 
mechanisms of therapeutic action of stem cells and to study the functional parameters of the visual 
analyzer (for example, to determine the evoked potentials of the optic nerve).
The study opens the prospects for cell therapy in the treatment of glaucoma optic neu-
ropathy in patients with glaucoma, which is one of the leading causes of blindness and disability 
worldwide today.
5. Conclusions
In this experiment, a positive effect of NCSCs transplantation was observed in an adrena-
line-induced glaucoma model. The intravenous administration of NCSCs reduced swelling in all 
retinal layers but did little to restore the cytoarchitectonics of the retinal layers. After the parabul-
bar administration of NCSCs, there was a decrease in edema and restoration of the cytoarchitec-
tonics of the retinal layers, most pronouncedly the retinal ganglion cell layer and in the inner retinal 
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layer. However, the most pronounced reduction in edema and restoration of the cytoarchitectonics 
of the retinal layers was observed after the retrobulbar administration of NCSCs.
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Abstract
The aim – to study the effectiveness of endoscopic photodynamic therapy as a preoperative preparation of the tracheobronchial 
tree in patients with lung cancer.
Materials and methods. The study included 181 patients with II–III stage of lung’s cancer. Diagnose of lung’s cancer was con-
firmed with a morphologically and concomitant endobronchitis. During the preoperative preparation, we used a technique developed by 
us introducing into the tracheobronchial tree an aqueous solution of brilliant green at concentration of 0.04 %, followed by irradiation of 
this solution with laser radiation with the wavelength of 0.63 μm (AFL-2 helium-neon laser) in an independent form and in combination 
with traditional anti-inflammatory therapy. Endoscopic endobronchial sanitation therapy was carried out by low-intensity radiation of 
the red part of the spectrum (λ=0.63–0.66 μm) in a pulsed mode, with a power of 12 mW. 
Results. After 3–5 days of the start preoperative preparation and 1–2 sessions of endoscopic bronchosanation, the general state 
of patients was improved, the amount of sputum decreased and was changing from mucopurulent to mucous. To completely stop the 
clinical phenomena of endobronchitis, it was necessary to conduct 5–6 sessions of endoscopic photodynamic therapy according to our 
methodology, with the introduction of our method. In patients without pronounced clinical symptoms of concomitant chronic bronchitis, 
it was enough to complete only 3 sessions of bronchosanation.
Conclusion. Endoscopic photodynamic bronchosanation in the preoperative period in patients for correcting accompanying 
endobronchitis can significantly reduce or completely stop the clinical manifestations of endobronchitis in the shortest time and leads to 
a significant decrease in the number of endobronchial complications in surgical and combined treatment of lung cancer.
Keywords: preoperative preparation, endoscopic photodynamic therapy, complications.
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